The global endoscope reprocessing market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028.
Endoscopes are used in the early detection, diagnosis, and treatment of malignant gastrointestinal (GI) diseases. However, the risk of infection transmission associated with endoscopes is usually high due to their complex structure and diverse use in medical procedures. As a result, health agencies of several countries have implemented strict endoscope reprocessing protocols to improve safety and reduce the spread of infections. These protocols ensure that endoscopes undergo various steps of meticulous cleaning and disinfection before being reused on patients. Moreover, several manufacturers are introducing automated endoscope reprocessors (AERs) for consistent, accurate, and cost-effective operation. AERs help kill microorganisms on reusable endoscopes by exposing their outside surfaces and interior channels to high-level disinfectant or liquid chemical sterilant solutions.
Endoscope Reprocessing Market Trends:
The coronavirus disease (COVID-19) outbreak has led to an increase in the number of people experiencing various GI symptoms, such as nausea, vomiting, and diarrhea. This, along with the mortality risk associated with GI diseases, is positively influencing the need for endoscopy procedures across the globe to improve patient safety. Apart from this, the growing pediatric population, which is relatively more vulnerable to targeted diseases, is driving the demand for flexible endoscopes to diagnose and treat cancer and GI disorders. In addition, endoscopy devices are used to investigate unusual symptoms like dysphagia, diarrhea, weight loss, heartburn, and stool blood, which is propelling the adoption of endoscope reprocessing to prevent the risk of infection. Moreover, health agencies are conducting facility-level training programs to assist healthcare institutions in achieving a reliable, high-quality reprocessing of endoscopes. This, in confluence with the increasing focus on improving reprocessing guidelines, is anticipated to fuel the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global endoscope reprocessing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, process and end user.
Breakup by Product:
High-Level Disinfectants and Test Strips
Detergents and Wipes
Automated Endoscope Reprocessors
Endoscope Drying, Storage and Transport Systems
Breakup by Process:
Breakup by End User:
Hospitals and Clinics
Ambulatory Surgery Centers
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Sterilization Products (ASP) (Fortive Corporation), ARC Healthcare Solutions Inc., Belimed AG (Metall Zug AG), BES Rehab Ltd, Custom Ultrasonics Inc., Ecolab Inc., ENDO-TECHNIK W. Griesat GmbH (Albyn Medical S.L.), Getinge AB, HOYA Corporation, Metrex Research LLC, Olympus Corporation, Shinva Medical Instrument Co. Ltd., Steelco S.p.A. (Miele) and Steris plc.
Base Year of the Analysis
Product, Process, End User, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Advanced Sterilization Products (ASP) (Fortive Corporation), ARC Healthcare Solutions Inc., Belimed AG (Metall Zug AG), BES Rehab Ltd, Custom Ultrasonics Inc., Ecolab Inc., ENDO-TECHNIK W. Griesat GmbH (Albyn Medical S.L.), Getinge AB, HOYA Corporation, Metrex Research LLC, Olympus Corporation, Shinva Medical Instrument Co. Ltd., Steelco S.p.A. (Miele) and Steris plc
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global endoscope reprocessing market was valued at US$ 2.0 Billion in 2022.
We expect the global endoscope reprocessing market to exhibit a CAGR of 7.6% during 2023-2028.
The sudden outbreak of the COVID-19 pandemic has led to rising demand for endoscope reprocessing to treat the coronavirus-infected patients with gastrointestinal disease symptoms, such as nausea, vomiting, and diarrhea.
The growing adoption of endoscope reprocessing to prevent the risk of infection and to improve patient safety from unusual symptoms, including dysphagia, diarrhea, weight loss, etc., is primarily driving the global endoscope reprocessing market.
Based on the product, the global endoscope reprocessing market can be categorized into high-level disinfectants and test strips, detergents and wipes, automated endoscope reprocessors, endoscope drying, storage and transport systems, and others. Among these, high-level disinfectants and test strips account for the majority of the total market share.
Based on the process, the global endoscope reprocessing market has been segregated into manual cleaning and automated cleaning, where automated cleaning currently holds the largest market share.
Based on the end user, the global endoscope reprocessing market can be bifurcated into hospitals and clinics, ambulatory surgery centers, and others. Currently, hospitals and clinics exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global endoscope reprocessing market include Advanced Sterilization Products (ASP) (Fortive Corporation), ARC Healthcare Solutions Inc., Belimed AG (Metall Zug AG), BES Rehab Ltd, Custom Ultrasonics Inc., Ecolab Inc., ENDO-TECHNIK W. Griesat GmbH (Albyn Medical S.L.), Getinge AB, HOYA Corporation, Metrex Research LLC, Olympus Corporation, Shinva Medical Instrument Co. Ltd., Steelco S.p.A. (Miele) and Steris plc.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.